Press Releases

Mar 02, 2020
SIGA Announces Collaboration with Turnstone Biologics
SIGA to supply TPOXX ® To Support Turnstone’s SKV Vaccinia Oncolytic Viral Immunotherapy Program NEW YORK , March 02, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it
Displaying 11 - 12 of 12